APO Research
Talk to an analyst

APO RESEARCH · REPORT

Histone Deacetylase 2

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Histone Deacetylase 2 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025199 pages

Choose your research edition.

Industry ResearchHistone Deacetylase 2 Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Histone Deacetylase 2 Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Histone Deacetylase 2 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Histone Deacetylase 2 Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Histone Deacetylase 2 Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Histone Deacetylase 2 market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Histone Deacetylase 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Histone Deacetylase 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Histone Deacetylase 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Histone Deacetylase 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Histone Deacetylase 2 include 4SC AG, Merck & Co., Inc., GlaxoSmithKline Plc, Yungjin Pharm. Co., Ltd., TetraLogic Pharmaceuticals, Sigma-Tau S.p.A., Rodin Therapeutics, MEI Pharma, Inc. and Italfarmaco S.p.A., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Histone Deacetylase 2 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Histone Deacetylase 2 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Histone Deacetylase 2 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Histone Deacetylase 2 market size, projected growth trends, production technologies, key applications, and end-use industries.

Histone Deacetylase 2 Segment by Company

4SC AG

Merck & Co., Inc.

GlaxoSmithKline Plc

Yungjin Pharm. Co., Ltd.

TetraLogic Pharmaceuticals

Sigma-Tau S.p.A.

Rodin Therapeutics

MEI Pharma, Inc.

Italfarmaco S.p.A.

HitGen LTD

Curis, Inc.

Chipscreen Biosciences Ltd

Acetylon Pharmaceuticals, Inc.

Histone Deacetylase 2 Segment by Type

ACY-957

CS-3158

HG-3001

RCY-1305

Others

Histone Deacetylase 2 Segment by Application

Bladder Cancer

Non-Hodgkin Lymphoma

Colon Cancer

Alopecia

Others

Histone Deacetylase 2 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Histone Deacetylase 2 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Histone Deacetylase 2 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Histone Deacetylase 2.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Histone Deacetylase 2 market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Histone Deacetylase 2 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Histone Deacetylase 2 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Histone Deacetylase 2 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Histone Deacetylase 2 Industry Trends Table 2. Histone Deacetylase 2 Industry Drivers Table 3. Histone Deacetylase 2 Industry Opportunities and Challenges Table 4. Histone Deacetylase 2 Industry Restraints Table 5. Global Histone Deacetylase 2 Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Histone Deacetylase 2 Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Histone Deacetylase 2 Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Histone Deacetylase 2 Sales Market Share by Manufacturers Table 9. Global Histone Deacetylase 2 Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Histone Deacetylase 2 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Histone Deacetylase 2 Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Histone Deacetylase 2 Manufacturers, Product Type & Application Table 13. Global Histone Deacetylase 2 Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Histone Deacetylase 2 by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of ACY-957 Table 17. Major Manufacturers of CS-3158 Table 18. Major Manufacturers of HG-3001 Table 19. Major Manufacturers of RCY-1305 Table 20. Major Manufacturers of Others Table 21. Global Histone Deacetylase 2 Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Histone Deacetylase 2 Sales by Type (2021-2026) & (K Units) Table 23. Global Histone Deacetylase 2 Sales by Type (2027-2032) & (K Units) Table 24. Global Histone Deacetylase 2 Sales Market Share by Type (2021-2026) Table 25. Global Histone Deacetylase 2 Sales Market Share by Type (2027-2032) Table 26. Global Histone Deacetylase 2 Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 27. Global Histone Deacetylase 2 Revenue by Type (2021-2026) & (K Units) Table 28. Global Histone Deacetylase 2 Revenue by Type (2027-2032) & (K Units) Table 29. Global Histone Deacetylase 2 Revenue Market Share by Type (2021-2026) Table 30. Global Histone Deacetylase 2 Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Bladder Cancer Table 32. Major Manufacturers of Non-Hodgkin Lymphoma Table 33. Major Manufacturers of Colon Cancer Table 34. Major Manufacturers of Alopecia Table 35. Major Manufacturers of Others Table 36. Global Histone Deacetylase 2 Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Histone Deacetylase 2 Sales by Application (2021-2026) & (K Units) Table 38. Global Histone Deacetylase 2 Sales by Application (2027-2032) & (K Units) Table 39. Global Histone Deacetylase 2 Sales Market Share by Application (2021-2026) Table 40. Global Histone Deacetylase 2 Sales Market Share by Application (2027-2032) Table 41. Global Histone Deacetylase 2 Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 42. Global Histone Deacetylase 2 Revenue by Application (2021-2026) & (K Units) Table 43. Global Histone Deacetylase 2 Revenue by Application (2027-2032) & (K Units) Table 44. Global Histone Deacetylase 2 Revenue Market Share by Application (2021-2026) Table 45. Global Histone Deacetylase 2 Revenue Market Share by Application (2027-2032) Table 46. Global Histone Deacetylase 2 Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 47. Global Histone Deacetylase 2 Sales by Region (2021-2026) & (K Units) Table 48. Global Histone Deacetylase 2 Sales Market Share by Region (2021-2026) Table 49. Global Histone Deacetylase 2 Sales Forecasted by Region (2027-2032) & (K Units) Table 50. Global Histone Deacetylase 2 Sales Forecasted Market Share by Region (2027-2032) Table 51. North America Histone Deacetylase 2 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. North America Histone Deacetylase 2 Sales by Country (2021-2026) & (K Units) Table 53. North America Histone Deacetylase 2 Sales by Country (2027-2032) & (K Units) Table 54. Europe Histone Deacetylase 2 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Europe Histone Deacetylase 2 Sales by Country (2021-2026) & (K Units) Table 56. Europe Histone Deacetylase 2 Sales by Country (2027-2032) & (K Units) Table 57. Asia Pacific Histone Deacetylase 2 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Asia Pacific Histone Deacetylase 2 Sales by Country (2021-2026) & (K Units) Table 59. Asia Pacific Histone Deacetylase 2 Sales by Country (2027-2032) & (K Units) Table 60. South America, Middle East and Africa Histone Deacetylase 2 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 61. South America, Middle East and Africa Histone Deacetylase 2 Sales by Country (2021-2026) & (K Units) Table 62. South America, Middle East and Africa Histone Deacetylase 2 Sales by Country (2027-2032) & (K Units) Table 63. Global Histone Deacetylase 2 Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 64. Global Histone Deacetylase 2 Revenue by Region (2021-2026) & (US$ Million) Table 65. Global Histone Deacetylase 2 Revenue by Region (2027-2032) & (US$ Million) Table 66. Global Histone Deacetylase 2 Revenue Market Share by Region (2021-2026) Table 67. Global Histone Deacetylase 2 Revenue Market Share by Region (2027-2032) Table 68. 4SC AG Company Information Table 69. 4SC AG Business Overview Table 70. 4SC AG Histone Deacetylase 2 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. 4SC AG Histone Deacetylase 2 Product Portfolio Table 72. 4SC AG Recent Development Table 73. Merck & Co., Inc. Company Information Table 74. Merck & Co., Inc. Business Overview Table 75. Merck & Co., Inc. Histone Deacetylase 2 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Merck & Co., Inc. Histone Deacetylase 2 Product Portfolio Table 77. Merck & Co., Inc. Recent Development Table 78. GlaxoSmithKline Plc Company Information Table 79. GlaxoSmithKline Plc Business Overview Table 80. GlaxoSmithKline Plc Histone Deacetylase 2 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. GlaxoSmithKline Plc Histone Deacetylase 2 Product Portfolio Table 82. GlaxoSmithKline Plc Recent Development Table 83. Yungjin Pharm. Co., Ltd. Company Information Table 84. Yungjin Pharm. Co., Ltd. Business Overview Table 85. Yungjin Pharm. Co., Ltd. Histone Deacetylase 2 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Yungjin Pharm. Co., Ltd. Histone Deacetylase 2 Product Portfolio Table 87. Yungjin Pharm. Co., Ltd. Recent Development Table 88. TetraLogic Pharmaceuticals Company Information Table 89. TetraLogic Pharmaceuticals Business Overview Table 90. TetraLogic Pharmaceuticals Histone Deacetylase 2 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. TetraLogic Pharmaceuticals Histone Deacetylase 2 Product Portfolio Table 92. TetraLogic Pharmaceuticals Recent Development Table 93. Sigma-Tau S.p.A. Company Information Table 94. Sigma-Tau S.p.A. Business Overview Table 95. Sigma-Tau S.p.A. Histone Deacetylase 2 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Sigma-Tau S.p.A. Histone Deacetylase 2 Product Portfolio Table 97. Sigma-Tau S.p.A. Recent Development Table 98. Rodin Therapeutics Company Information Table 99. Rodin Therapeutics Business Overview Table 100. Rodin Therapeutics Histone Deacetylase 2 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Rodin Therapeutics Histone Deacetylase 2 Product Portfolio Table 102. Rodin Therapeutics Recent Development Table 103. MEI Pharma, Inc. Company Information Table 104. MEI Pharma, Inc. Business Overview Table 105. MEI Pharma, Inc. Histone Deacetylase 2 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. MEI Pharma, Inc. Histone Deacetylase 2 Product Portfolio Table 107. MEI Pharma, Inc. Recent Development Table 108. Italfarmaco S.p.A. Company Information Table 109. Italfarmaco S.p.A. Business Overview Table 110. Italfarmaco S.p.A. Histone Deacetylase 2 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Italfarmaco S.p.A. Histone Deacetylase 2 Product Portfolio Table 112. Italfarmaco S.p.A. Recent Development Table 113. HitGen LTD Company Information Table 114. HitGen LTD Business Overview Table 115. HitGen LTD Histone Deacetylase 2 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. HitGen LTD Histone Deacetylase 2 Product Portfolio Table 117. HitGen LTD Recent Development Table 118. Curis, Inc. Company Information Table 119. Curis, Inc. Business Overview Table 120. Curis, Inc. Histone Deacetylase 2 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Curis, Inc. Histone Deacetylase 2 Product Portfolio Table 122. Curis, Inc. Recent Development Table 123. Chipscreen Biosciences Ltd Company Information Table 124. Chipscreen Biosciences Ltd Business Overview Table 125. Chipscreen Biosciences Ltd Histone Deacetylase 2 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Chipscreen Biosciences Ltd Histone Deacetylase 2 Product Portfolio Table 127. Chipscreen Biosciences Ltd Recent Development Table 128. Acetylon Pharmaceuticals, Inc. Company Information Table 129. Acetylon Pharmaceuticals, Inc. Business Overview Table 130. Acetylon Pharmaceuticals, Inc. Histone Deacetylase 2 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Acetylon Pharmaceuticals, Inc. Histone Deacetylase 2 Product Portfolio Table 132. Acetylon Pharmaceuticals, Inc. Recent Development Table 133. Key Raw Materials Table 134. Raw Materials Key Suppliers Table 135. Histone Deacetylase 2 Distributors List Table 136. Histone Deacetylase 2 Customers List Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. Histone Deacetylase 2 Product Image Figure 2. Global Histone Deacetylase 2 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Histone Deacetylase 2 Market Size (2021-2032) & (US$ Million) Figure 4. Global Histone Deacetylase 2 Sales (2021-2032) & (K Units) Figure 5. Global Histone Deacetylase 2 Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Histone Deacetylase 2 Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. ACY-957 Image Figure 9. CS-3158 Image Figure 10. HG-3001 Image Figure 11. RCY-1305 Image Figure 12. Others Image Figure 13. Global Histone Deacetylase 2 Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Histone Deacetylase 2 Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Histone Deacetylase 2 Sales Market Share by Type (2021-2032) Figure 16. Global Histone Deacetylase 2 Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global Histone Deacetylase 2 Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Histone Deacetylase 2 Revenue Market Share by Type (2021-2032) Figure 19. Bladder Cancer Image Figure 20. Non-Hodgkin Lymphoma Image Figure 21. Colon Cancer Image Figure 22. Alopecia Image Figure 23. Others Image Figure 24. Global Histone Deacetylase 2 Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Histone Deacetylase 2 Sales Market Share 2021 VS 2025 VS 2032 Figure 26. Global Histone Deacetylase 2 Sales Market Share by Application (2021-2032) Figure 27. Global Histone Deacetylase 2 Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 28. Global Histone Deacetylase 2 Revenue Market Share 2021 VS 2025 VS 2032 Figure 29. Global Histone Deacetylase 2 Revenue Market Share by Application (2021-2032) Figure 30. North America Histone Deacetylase 2 Sales and Growth Rate (2021-2032) & (K Units) Figure 31. North America Histone Deacetylase 2 Sales Market Share by Country (2021-2032) Figure 32. U.S. Histone Deacetylase 2 Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Canada Histone Deacetylase 2 Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Mexico Histone Deacetylase 2 Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Europe Histone Deacetylase 2 Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Europe Histone Deacetylase 2 Sales Market Share by Country (2021-2032) Figure 37. Germany Histone Deacetylase 2 Sales and Growth Rate (2021-2032) & (K Units) Figure 38. France Histone Deacetylase 2 Sales and Growth Rate (2021-2032) & (K Units) Figure 39. U.K. Histone Deacetylase 2 Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Italy Histone Deacetylase 2 Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Netherlands Histone Deacetylase 2 Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Asia Pacific Histone Deacetylase 2 Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Asia Pacific Histone Deacetylase 2 Sales Market Share by Country (2021-2032) Figure 44. China Histone Deacetylase 2 Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Japan Histone Deacetylase 2 Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South Korea Histone Deacetylase 2 Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Southeast Asia Histone Deacetylase 2 Sales and Growth Rate (2021-2032) & (K Units) Figure 48. India Histone Deacetylase 2 Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Australia Histone Deacetylase 2 Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South America, Middle East and Africa Histone Deacetylase 2 Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South America, Middle East and Africa Histone Deacetylase 2 Sales Market Share by Country (2021-2032) Figure 52. Brazil Histone Deacetylase 2 Sales and Growth Rate (2021-2032) & (K Units) Figure 53. South Africa Histone Deacetylase 2 Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Saudi Arabia Histone Deacetylase 2 Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Turkey Histone Deacetylase 2 Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Argentina Histone Deacetylase 2 Sales and Growth Rate (2021-2032) & (K Units) Figure 57. UAE Histone Deacetylase 2 Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Egypt Histone Deacetylase 2 Sales and Growth Rate (2021-2032) & (K Units) Figure 59. Chile Histone Deacetylase 2 Sales and Growth Rate (2021-2032) & (K Units) Figure 60. Global Histone Deacetylase 2 Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Global Histone Deacetylase 2 Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 62. North America Histone Deacetylase 2 Revenue (2021-2032) & (US$ Million) Figure 63. North America Histone Deacetylase 2 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Europe Histone Deacetylase 2 Revenue (2021-2032) & (US$ Million) Figure 65. Europe Histone Deacetylase 2 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Asia-Pacific Histone Deacetylase 2 Revenue (2021-2032) & (US$ Million) Figure 67. Asia-Pacific Histone Deacetylase 2 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. South America, Middle East and Africa Histone Deacetylase 2 Revenue (2021-2032) & (US$ Million) Figure 69. South America, Middle East and Africa Histone Deacetylase 2 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. Histone Deacetylase 2 Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Histone Deacetylase 2 Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • ACY-957
  • CS-3158
  • HG-3001
  • RCY-1305
  • Others
Applications
  • Bladder Cancer
  • Non-Hodgkin Lymphoma
  • Colon Cancer
  • Alopecia
  • Others
Companies covered
  • 4SC AG
  • Merck & Co., Inc.
  • GlaxoSmithKline Plc
  • Yungjin Pharm. Co., Ltd.
  • TetraLogic Pharmaceuticals
  • Sigma-Tau S.p.A.
  • Rodin Therapeutics
  • MEI Pharma, Inc.
  • Italfarmaco S.p.A.
  • HitGen LTD
  • Curis, Inc.
  • Chipscreen Biosciences Ltd
  • Acetylon Pharmaceuticals, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Histone Deacetylase 2 Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Histone Deacetylase 2 Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Histone Deacetylase 2 Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Histone Deacetylase 2 Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Histone Deacetylase 2 Market Dynamics
  1. 2.1 Histone Deacetylase 2 Industry Trends
  2. 2.2 Histone Deacetylase 2 Industry Drivers
  3. 2.3 Histone Deacetylase 2 Industry Opportunities and Challenges
  4. 2.4 Histone Deacetylase 2 Industry Restraints
3 Histone Deacetylase 2 Market by Manufacturers
  1. 3.1 Global Histone Deacetylase 2 Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Histone Deacetylase 2 Sales by Manufacturers (2021-2026)
  3. 3.3 Global Histone Deacetylase 2 Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Histone Deacetylase 2 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Histone Deacetylase 2 Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Histone Deacetylase 2 Manufacturers, Product Type & Application
  7. 3.7 Global Histone Deacetylase 2 Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Histone Deacetylase 2 Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Histone Deacetylase 2 Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Histone Deacetylase 2 Tier 1, Tier 2, and Tier 3
4 Histone Deacetylase 2 Market by Type
  1. 4.1 Histone Deacetylase 2 Type Introduction
  2. 4.1.1 ACY-957
  3. 4.1.2 CS-3158
  4. 4.1.3 HG-3001
  5. 4.1.4 RCY-1305
  6. 4.1.5 Others
  7. 4.2 Global Histone Deacetylase 2 Sales by Type
  8. 4.2.1 Global Histone Deacetylase 2 Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Histone Deacetylase 2 Sales by Type (2021-2032)
  10. 4.2.3 Global Histone Deacetylase 2 Sales Market Share by Type (2021-2032)
  11. 4.3 Global Histone Deacetylase 2 Revenue by Type
  12. 4.3.1 Global Histone Deacetylase 2 Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Histone Deacetylase 2 Revenue by Type (2021-2032)
  14. 4.3.3 Global Histone Deacetylase 2 Revenue Market Share by Type (2021-2032)
5 Histone Deacetylase 2 Market by Application
  1. 5.1 Histone Deacetylase 2 Application Introduction
  2. 5.1.1 Bladder Cancer
  3. 5.1.2 Non-Hodgkin Lymphoma
  4. 5.1.3 Colon Cancer
  5. 5.1.4 Alopecia
  6. 5.1.5 Others
  7. 5.2 Global Histone Deacetylase 2 Sales by Application
  8. 5.2.1 Global Histone Deacetylase 2 Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Histone Deacetylase 2 Sales by Application (2021-2032)
  10. 5.2.3 Global Histone Deacetylase 2 Sales Market Share by Application (2021-2032)
  11. 5.3 Global Histone Deacetylase 2 Revenue by Application
  12. 5.3.1 Global Histone Deacetylase 2 Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Histone Deacetylase 2 Revenue by Application (2021-2032)
  14. 5.3.3 Global Histone Deacetylase 2 Revenue Market Share by Application (2021-2032)
6 Global Histone Deacetylase 2 Sales by Region
  1. 6.1 Global Histone Deacetylase 2 Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Histone Deacetylase 2 Sales by Region (2021-2032)
  3. 6.2.1 Global Histone Deacetylase 2 Sales by Region (2021-2026)
  4. 6.2.2 Global Histone Deacetylase 2 Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Histone Deacetylase 2 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Histone Deacetylase 2 Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Histone Deacetylase 2 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Histone Deacetylase 2 Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Histone Deacetylase 2 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Histone Deacetylase 2 Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Histone Deacetylase 2 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Histone Deacetylase 2 Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Histone Deacetylase 2 Revenue by Region
  1. 7.1 Global Histone Deacetylase 2 Revenue by Region
  2. 7.1.1 Global Histone Deacetylase 2 Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Histone Deacetylase 2 Revenue by Region (2021-2026)
  4. 7.1.3 Global Histone Deacetylase 2 Revenue by Region (2027-2032)
  5. 7.1.4 Global Histone Deacetylase 2 Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Histone Deacetylase 2 Revenue (2021-2032)
  8. 7.2.2 North America Histone Deacetylase 2 Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Histone Deacetylase 2 Revenue (2021-2032)
  11. 7.3.2 Europe Histone Deacetylase 2 Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Histone Deacetylase 2 Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Histone Deacetylase 2 Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Histone Deacetylase 2 Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Histone Deacetylase 2 Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 4SC AG
  2. 8.1.1 4SC AG Company Information
  3. 8.1.2 4SC AG Business Overview
  4. 8.1.3 4SC AG Histone Deacetylase 2 Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 4SC AG Histone Deacetylase 2 Product Portfolio
  6. 8.1.5 4SC AG Recent Developments
  7. 8.2 Merck & Co., Inc.
  8. 8.2.1 Merck & Co., Inc. Company Information
  9. 8.2.2 Merck & Co., Inc. Business Overview
  10. 8.2.3 Merck & Co., Inc. Histone Deacetylase 2 Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Merck & Co., Inc. Histone Deacetylase 2 Product Portfolio
  12. 8.2.5 Merck & Co., Inc. Recent Developments
  13. 8.3 GlaxoSmithKline Plc
  14. 8.3.1 GlaxoSmithKline Plc Company Information
  15. 8.3.2 GlaxoSmithKline Plc Business Overview
  16. 8.3.3 GlaxoSmithKline Plc Histone Deacetylase 2 Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 GlaxoSmithKline Plc Histone Deacetylase 2 Product Portfolio
  18. 8.3.5 GlaxoSmithKline Plc Recent Developments
  19. 8.4 Yungjin Pharm. Co., Ltd.
  20. 8.4.1 Yungjin Pharm. Co., Ltd. Company Information
  21. 8.4.2 Yungjin Pharm. Co., Ltd. Business Overview
  22. 8.4.3 Yungjin Pharm. Co., Ltd. Histone Deacetylase 2 Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Yungjin Pharm. Co., Ltd. Histone Deacetylase 2 Product Portfolio
  24. 8.4.5 Yungjin Pharm. Co., Ltd. Recent Developments
  25. 8.5 TetraLogic Pharmaceuticals
  26. 8.5.1 TetraLogic Pharmaceuticals Company Information
  27. 8.5.2 TetraLogic Pharmaceuticals Business Overview
  28. 8.5.3 TetraLogic Pharmaceuticals Histone Deacetylase 2 Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 TetraLogic Pharmaceuticals Histone Deacetylase 2 Product Portfolio
  30. 8.5.5 TetraLogic Pharmaceuticals Recent Developments
  31. 8.6 Sigma-Tau S.p.A.
  32. 8.6.1 Sigma-Tau S.p.A. Company Information
  33. 8.6.2 Sigma-Tau S.p.A. Business Overview
  34. 8.6.3 Sigma-Tau S.p.A. Histone Deacetylase 2 Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sigma-Tau S.p.A. Histone Deacetylase 2 Product Portfolio
  36. 8.6.5 Sigma-Tau S.p.A. Recent Developments
  37. 8.7 Rodin Therapeutics
  38. 8.7.1 Rodin Therapeutics Company Information
  39. 8.7.2 Rodin Therapeutics Business Overview
  40. 8.7.3 Rodin Therapeutics Histone Deacetylase 2 Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Rodin Therapeutics Histone Deacetylase 2 Product Portfolio
  42. 8.7.5 Rodin Therapeutics Recent Developments
  43. 8.8 MEI Pharma, Inc.
  44. 8.8.1 MEI Pharma, Inc. Company Information
  45. 8.8.2 MEI Pharma, Inc. Business Overview
  46. 8.8.3 MEI Pharma, Inc. Histone Deacetylase 2 Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 MEI Pharma, Inc. Histone Deacetylase 2 Product Portfolio
  48. 8.8.5 MEI Pharma, Inc. Recent Developments
  49. 8.9 Italfarmaco S.p.A.
  50. 8.9.1 Italfarmaco S.p.A. Company Information
  51. 8.9.2 Italfarmaco S.p.A. Business Overview
  52. 8.9.3 Italfarmaco S.p.A. Histone Deacetylase 2 Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Italfarmaco S.p.A. Histone Deacetylase 2 Product Portfolio
  54. 8.9.5 Italfarmaco S.p.A. Recent Developments
  55. 8.10 HitGen LTD
  56. 8.10.1 HitGen LTD Company Information
  57. 8.10.2 HitGen LTD Business Overview
  58. 8.10.3 HitGen LTD Histone Deacetylase 2 Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 HitGen LTD Histone Deacetylase 2 Product Portfolio
  60. 8.10.5 HitGen LTD Recent Developments
  61. 8.11 Curis, Inc.
  62. 8.11.1 Curis, Inc. Company Information
  63. 8.11.2 Curis, Inc. Business Overview
  64. 8.11.3 Curis, Inc. Histone Deacetylase 2 Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Curis, Inc. Histone Deacetylase 2 Product Portfolio
  66. 8.11.5 Curis, Inc. Recent Developments
  67. 8.12 Chipscreen Biosciences Ltd
  68. 8.12.1 Chipscreen Biosciences Ltd Company Information
  69. 8.12.2 Chipscreen Biosciences Ltd Business Overview
  70. 8.12.3 Chipscreen Biosciences Ltd Histone Deacetylase 2 Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Chipscreen Biosciences Ltd Histone Deacetylase 2 Product Portfolio
  72. 8.12.5 Chipscreen Biosciences Ltd Recent Developments
  73. 8.13 Acetylon Pharmaceuticals, Inc.
  74. 8.13.1 Acetylon Pharmaceuticals, Inc. Company Information
  75. 8.13.2 Acetylon Pharmaceuticals, Inc. Business Overview
  76. 8.13.3 Acetylon Pharmaceuticals, Inc. Histone Deacetylase 2 Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Acetylon Pharmaceuticals, Inc. Histone Deacetylase 2 Product Portfolio
  78. 8.13.5 Acetylon Pharmaceuticals, Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Histone Deacetylase 2 Value Chain Analysis
  2. 9.1.1 Histone Deacetylase 2 Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Histone Deacetylase 2 Production Mode & Process
  6. 9.2 Histone Deacetylase 2 Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Histone Deacetylase 2 Distributors
  9. 9.2.3 Histone Deacetylase 2 Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst